Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Vaccines

Free Subscription 08.03.2010 3 Arch Virol 3 BMJ 1 Clin Infect Dis 2 Infect Immun 1 J Gen Virol 3 J Infect Dis 3 J Virol 1 JAMA 1 Lancet 1 N Engl J Med 2 Pediatr Infect Dis J 3 Pediatrics 1 Science 57 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Arch Virol

1. SUI Z , Chen Q, Wu R, Zhang H, et al
   Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
   Arch Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
2. A BAUMANN C , J Neubert W
   Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection.
   Arch Virol. 2010;155:217-27.
   PubMed     Text format     Related articles    Abstract available
   
   
3. ZHANG Y , Zhang F, Zhu S, Chen L, et al
   A Sabin 2-related poliovirus recombinant contains a homologous sequence of human enterovirus species C in the viral polymerase coding region.
   Arch Virol. 2010;155:197-205.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   BMJ

4. WACHOLDER S , Chen BE, Wilcox A, Macones G, et al
   Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials.
   BMJ. 2010;340:c712.
   PubMed     Text format     Related articles    Abstract available
   
   
5. DYER C
   Lancet retracts Wakefield's MMR paper.
   BMJ. 2010;340:c696.
   PubMed     Text format     Related articles   
   
   
6. GREENHALGH T
   Why did the Lancet take so long?
   BMJ. 2010;340:c644.
   PubMed     Text format     Related articles   
   
   

   
   Clin Infect Dis

7. O'GRADY KA , Lee KJ, Carlin JB, Torzillo PJ, et al
   Increased Risk of Hospitalization for Acute Lower Respiratory Tract Infection among Australian Indigenous Infants 5-23 Months of Age Following Pneumococcal Vaccination: A Cohort Study.
   Clin Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   Infect Immun

8. MAUDUIT M , Tewari R, Depinay N, Kayibanda M, et al
   A minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites.
   Infect Immun. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
9. TRANT CG , Lacerda TL, Carvalho NB, Azevedo V, et al
   Brucella abortus phosphoglycerate kinase (pgk) mutant is highly attenuated and induces superior protection than vaccine strain 19 in immune compromised and immune competent mice.
   Infect Immun. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   J Gen Virol

10. BREIMAN A , Smith GL
    The vaccinia virus B5 protein affects the glycosylation, localisation and stability of the A34 protein.
    J Gen Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Infect Dis

11. HARRISON LH , Shutt KA, Schmink SE, Marsh JW, et al
    Population Structure and Capsular Switching of Invasive Neisseria meningitidis Isolates in the Pre-Meningococcal Conjugate Vaccine Era-United States, 2000-2005.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
12. ZHANG W , Ahmad G, Torben W, Noor Z, et al
    Sm-p80-Based DNA Vaccine Provides Baboons with Levels of Protection against Schistosoma mansoni Infection Comparable to Those Achieved by the Irradiated Cercarial Vaccine.
    J Infect Dis. 2010;201:1105-12.
    PubMed     Text format     Related articles    Abstract available
    
    
13. LANDAVERDE JM , Danovaro-Holliday MC, Trumbo SP, Pacis-Tirso CL, et al
    Guillain-Barre Syndrome in Children Aged <15 Years in Latin America and the Caribbean: Baseline Rates in the Context of the Influenza A (H1N1) Pandemic.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Virol

14. FREEL SA , Lamoreaux L, Chattopadhyay PK, Saunders K, et al
    Phenotypic and Functional Profile of HIV-inhibitory CD8 T cells Elicited by Natural Infection and Heterologous Prime/boost Vaccination.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
15. DOUAGI I , Forsell MN, Sundling C, O'dell S, et al
    Influence of Novel CD4 binding-defective HIV-1 Envelope Glycoprotein Immunogens on Neutralizing Antibody and T Cell Responses in Non-human Primates.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
16. MUELLER SN , Langley WA, Carnero E, Garcia-Sastre A, et al
    Immunization with live-attenuated influenza viruses expressing altered NS1 proteins results in potent and protective memory CD8+ T cells responses.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    JAMA

17. KUEHN BM
    Report: Too little surveillance, treatment for US patients with hepatitis B and C.
    JAMA. 2010;303:713-4.
    PubMed     Text format     Related articles   
    
    

    
    Lancet

18. OMER SB , Hiremath GS, Halsey NA
    Respiratory administration of measles vaccine.
    Lancet. 2010;375:706-8.
    PubMed     Text format     Related articles   
    
    

    
    N Engl J Med

19. FRENCH N , Gordon SB, Mwalukomo T, White SA, et al
    A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults.
    N Engl J Med. 2010;362:812-22.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Pediatr Infect Dis J

20. LOPEZ EL , Contrini MM, Mistchenko A, Debbag R, et al
    Long-Term Immunity After Two Doses of Inactivated Hepatitis A Vaccine, in Argentinean Children.
    Pediatr Infect Dis J. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
21. KLEIN NP , Hansen J, Lewis E, Lyon L, et al
    Post-Marketing Safety Evaluation of a Tetanus Toxoid, Reduced Diphtheria Toxoid and 3-Component Acellular Pertussis Vaccine Administered to a Cohort of Adolescents in a United States Health Maintenance Organization.
    Pediatr Infect Dis J. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Pediatrics

22. CHOULIARAS G , Spoulou V, Quinlivan M, Breuer J, et al
    Vaccine-associated Herpes Zoster Opthalmicus and Encephalitis in an Immunocompetent Child.
    Pediatrics. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
23. FREED GL , Clark SJ, Butchart AT, Singer DC, et al
    Parental Vaccine Safety Concerns in 2009.
    Pediatrics. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
24. FLORES AR , Szilagyi PG, Auinger P, Fisher SG, et al
    Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States.
    Pediatrics. 2010;125:e191-8.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Science

25. COUZIN-FRANKEL J
    Drug safety. New network to track drugs and vaccines in pregnancy.
    Science. 2010;327:1066-7.
    PubMed     Text format     Related articles   
    
    

    
    Vaccine

26. JONGWUTIWES S , Putaporntip C, Hughes AL
    Bottleneck effects on vaccine-candidate antigen diversity of malaria parasites in Thailand.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
27. RUSSELL FM , Licciardi PV, Balloch A, Biaukula V, et al
    Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or threes doses of the 7-valent pneumococcal conjugate vaccine in infancy.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
28. BRISSON M , Melkonyan G, Drolet M, De Serres G, et al
    Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
29. FOWLER VL , Knowles NJ, Paton DJ, Barnett PV, et al
    Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
30. VERMINNEN K , Beeckman DS, Sanders NN, De Smedt S, et al
    Vaccination of turkeys against Chlamydophila psittaci through optimised DNA formulation and administration.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
31. SRIFEUNGFUNG S , Tribuddharat C, Comerungsee S, Chatsuwan T, et al
    Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
32. ROBBINS SC , Bernard D, McCaffery K, Brotherton J, et al
    "Is cancer contagious?": Australian adolescent girls and their parents: Making the most of limited information about HPV and HPV vaccination.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
33. HALM A , Yalcouye I, Kamissoko M, Keita T, et al
    Using oral polio vaccine beyond the cold chain: A feasibility study conducted during the national immunization campaign in Mali.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
34. PLUHAR GE , Grogan PG, Seiler C, Goulart M, et al
    Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
35. FRAZAO N , Sa-Leao R, de Lencastre H
    Impact of a single dose of the 7-valent pneumococcal conjugate vaccine on colonization.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
36. ATCHISON C , Lopman B, Edmunds WJ
    Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
37. LA TORRE G , de Waure C, Chiaradia G, Mannocci A, et al
    The Health Technology Assessment of bivalent HPV vaccine Cervarix((R)) in Italy.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
38. MONTEIRO SA , Takano OA, Waldman EA
    Surveillance for adverse events after DTwP/Hib vaccination in Brazil: Sensitivity and factors associated with reporting.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
39. XUE X , Ding F, Zhang Q, Pan X, et al
    Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
40. LICCIARDI PV , Underwood JR
    Identification of a novel vaccine adjuvant that stimulates and maintains diphtheria toxoid immunity.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
41. CHEN W , Kuolee R, Yan H
    The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
42. HE C , Wang H, Wei H, Yan Y, et al
    A recombinant truncated FMDV 3AB protein used to better distinguish between infected and vaccinated cattle.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
43. MORERA Y , Bequet-Romero M, Ayala M, Velazco JC, et al
    Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
44. WANG D , Xu J, Feng Y, Liu Y, et al
    Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
45. YAMANAKA H , Hoyt T, Yang X, Bowen R, et al
    A parenteral DNA vaccine protects against pneumonic plague.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
46. EPP T , Waldner S, Wright J, Curry P, et al
    Characterizing the acceptability of a vaccine for West Nile virus by public health practitioners.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
47. MARTIN SS , Bakken RR, Lind CM, Garcia P, et al
    Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
48. CAILLET C , Piras F, Bernard MC, de Montfort A, et al
    AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
49. TREGNAGHI MW , Voelker R, Santos-Lima E, Zambrano B, et al
    Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
50. ARGUEDAS A , Soley C, Loaiza C, Rincon G, et al
    Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
51. ZOU Y , Sonderegger I, Lipowsky G, Jennings GT, et al
    Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
52. LIU PF , Shi W, Zhu W, Smith JW, et al
    Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
53. HOUWELING H , Verweij M, Ruitenberg EJ
    Criteria for inclusion of vaccinations in public programmes.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
54. HWANG SD , Shin JS, Ku KB, Kim HS, et al
    Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
55. BROCKHOFF HJ , Mollema L, Sonder GJ, Postema CA, et al
    Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
56. HARTGROVES LC , Koudstaal W, McLeod C, Moncorge O, et al
    Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
57. MARKOWITZ LE , Hariri S, Unger ER, Saraiya M, et al
    Post-licensure monitoring of HPV vaccine in the United States.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
58. YASHIMA S , Yoshizaki S, Shinoda K, Yoshida A, et al
    Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8 T cells.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
59. LORENZO G , Martin-Folgar R, Hevia E, Boshra H, et al
    Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
60. TSOLAKOS N , Lie K, Bolstad K, Maslen S, et al
    Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
61. NOLAND GS , Chowdhury DR, Urban JF Jr, Zavala F, et al
    Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
62. ZOU Q , Zhong Y, Su H, Kang Y, et al
    Enhancement of humoral and cellular responses to HBsAg DNA vaccination by immunization with praziquantel through inhibition TGF-beta/Smad2,3 signaling.
    Vaccine. 2010;28:2032-2038.
    PubMed     Text format     Related articles    Abstract available
    
    
63. WANG LX , Nagata T, Tsujimura K, Uchijima M, et al
    Identification of HLA-DR4-restricted T-cell epitope on MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis using MPT51 overlapping peptides screening and DNA vaccination.
    Vaccine. 2010;28:2026-2031.
    PubMed     Text format     Related articles    Abstract available
    
    
64. SUZUKI D , Nagata T, Eweda G, Matsumoto S, et al
    Characterization of murine T-cell epitopes on mycobacterial DNA-binding protein 1 (MDP1) using DNA vaccination.
    Vaccine. 2010;28:2020-2025.
    PubMed     Text format     Related articles    Abstract available
    
    
65. WANG S , Mboudjeka I, Goguen JD, Lu S, et al
    Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.
    Vaccine. 2010;28:2011-2019.
    PubMed     Text format     Related articles    Abstract available
    
    
66. JIN J , Ding Z, Meng F, Liu Q, et al
    An immunotherapeutic treatment against flea allergy dermatitis in cats by co-immunization of DNA and protein vaccines.
    Vaccine. 2010;28:1997-2004.
    PubMed     Text format     Related articles    Abstract available
    
    
67. VALENTIN A , von Gegerfelt A, Rosati M, Miteloudis G, et al
    Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit.
    Vaccine. 2010;28:1962-74.
    PubMed     Text format     Related articles    Abstract available
    
    
68. LEMIALE F , Asefa B, Ye D, Chen C, et al
    An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.
    Vaccine. 2010;28:1952-1961.
    PubMed     Text format     Related articles    Abstract available
    
    
69. YIN J , Dai A, Shen A, Lecureux J, et al
    Viral reservoir is suppressed but not eliminated by CD8 vaccine specific lymphocytes.
    Vaccine. 2010;28:1924-1931.
    PubMed     Text format     Related articles    Abstract available
    
    
70. KLINMAN DM , Klaschik S, Tomaru K, Shirota H, et al
    Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants.
    Vaccine. 2010;28:1919-23.
    PubMed     Text format     Related articles    Abstract available
    
    
71. LI L , Herndon JM, Truscott SM, Hansen TH, et al
    Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.
    Vaccine. 2010;28:1911-1918.
    PubMed     Text format     Related articles    Abstract available
    
    
72. LI A , Chen J, Hattori M, Franco E, et al
    A therapeutic DNA vaccination strategy for autoimmunity and transplantation.
    Vaccine. 2010;28:1897-1904.
    PubMed     Text format     Related articles    Abstract available
    
    
73. WEINER DB , Sardesai NY, Schmaljohn C
    Introduction to DNA vaccines - Las Vegas.
    Vaccine. 2010;28:1893-6.
    PubMed     Text format     Related articles   
    
    
74. DOUCE G , Ross K, Cowan G, Ma JT, et al
    Novel mucosal vaccines generated by genetic conjugation of heterologous proteins to pneumolysin (PLY) from Streptococcus pneumoniae.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
75. LYON CE , Sadigh KS, Carmolli MP, Harro C, et al
    In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7x10(10) colony-forming units.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
76. SPADACCINI A , Virnik K, Ni Y, Prutzman K, et al
    Stable expression of a foreign protein by a replication-competent rubella viral vector.
    Vaccine. 2010;28:1181-7.
    PubMed     Text format     Related articles    Abstract available
    
    
77. MARIAPPAN V , Vellasamy KM, Thimma JS, Hashim OH, et al
    Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis.
    Vaccine. 2010;28:1318-24.
    PubMed     Text format     Related articles    Abstract available
    
    
78. HOONAKKER ME , Ruiterkamp N, Hendriksen CF
    The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization test.
    Vaccine. 2010;28:1347-52.
    PubMed     Text format     Related articles    Abstract available
    
    
79. SELLERS H , Linneman E, Icard AH, Mundt E, et al
    A purified recombinant baculovirus expressed capsid protein of a new astrovirus provides partial protection to runting-stunting syndrome in chickens.
    Vaccine. 2010;28:1253-63.
    PubMed     Text format     Related articles    Abstract available
    
    
80. MCNEILLY TN , Mitchell MC, Nisbet AJ, McAteer S, et al
    IgA and IgG antibody responses following systemic immunization of cattle with native H7 flagellin differ in epitope recognition and capacity to neutralise TLR5 signalling.
    Vaccine. 2010;28:1412-21.
    PubMed     Text format     Related articles    Abstract available
    
    
81. GARATTINI L , Casadei G
    Confirming our previous comments.
    Vaccine. 2010;28:880.
    PubMed     Text format     Related articles   
    
    
82. NEWMAN PA , Roungprakhon S, Tepjan S, Yim S, et al
    Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: